Cetera Advisor Networks LLC Cassava Sciences Inc Transaction History

Cetera Advisor Networks LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$18.44 - $26.41 $57,256 - $82,003	3,105 Added 20.6%	18,180 $368,000
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $53,189 - $126,702	4,208 Added 38.72%	15,075 $339,000
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $180,826 - $275,152	10,867 New	10,867 $180,000
Q3 2022 Nov 10, 2022	BUY	$16.33 - $51.06 $328,902 - $1.03 Million	20,141 Added 171.71%	31,871 $1.33 Million
Q2 2022 Aug 11, 2022	SELL	$17.22 - $38.47 $228,027 - $509,419	-13,242 Reduced 53.03%	11,730 $330,000
Q1 2022 May 12, 2022	BUY	$32.6 - $53.05 $91,834 - $149,441	2,817 Added 12.71%	24,972 $927,000
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $149,286 - $369,094	4,060 Added 22.44%	22,155 $968,000
Q3 2021 Nov 16, 2021	BUY	$41.79 - $135.3 $336,325 - $1.09 Million	8,048 Added 80.1%	18,095 $1.12 Million
Q2 2021 Aug 13, 2021	BUY	$32.15 - $89.72 $17,103 - $47,731	532 Added 5.59%	10,047 $858,000
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $164,098 - $2.04 Million	-23,145 Reduced 70.87%	9,515 $428,000
Q4 2020 Feb 17, 2021	BUY	$6.79 - $12.25 $109,998 - $198,450	16,200 Added 98.42%	32,660 $223,000
Q3 2020 Nov 13, 2020	BUY	$2.86 - $11.51 $7,035 - $28,314	2,460 Added 17.57%	16,460 $189,000
Q2 2020 Aug 13, 2020	BUY	$2.04 - $9.64 $1,020 - $4,820	500 Added 3.7%	14,000 $43,000
Q1 2020 May 08, 2020	SELL	$3.26 - $9.65 $24,450 - $72,375	-7,500 Reduced 35.71%	13,500 $55,000
Q4 2019 Feb 10, 2020	BUY	$1.1 - $6.12 $23,100 - $128,520	21,000 New	21,000 $109,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $94.2M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.